![SR-3029 954pSer2 pSer5 pSer7]-CTD TFA ClH/c8-5-6-1-3-7(4-2-6)12(9](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M18687_1635163012.gif?v=1741429950)
Pay in 4 interest-free payments of $22.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
ClH/c8-5-6-1-3-7(4-2-6)12(9
Smiles: C[C@H](N[C@@H](CC1C=CC(=CC=1)C1=CC(Cl)=CC=C1)C(O)=O)C(=O)OCC
GSK2292767 is a potent and selective PI3Kδ inhibitor
Ibrutinib was approved by the US FDA on November 13
10(10):28-33
SR-3029 954pSer2 pSer5 pSer7]-CTD TFA ClH/c8-5-6-1-3-7(4-2-6)12(9SR 3029 is a potent and ATP competitive CK1 and CK1 inhibitor, with IC50s of 44 nM and 260 nM, respectively, and Kis of 97 nM for both kinases. Product information CAS Number: 1454585 06 8 Molecular Weight: 480. 45 Formula: C23H19F3N8O Chemical Name: N [(6,7 difluoro 1H 1,3 benzodiazol 2 yl)methyl] 9 (3 fluorophenyl) 2 (morpholin 4 yl) 9H purin 6 amine Smiles: FC1=CC(=CC=C1)N1C=NC2=C(NCC3NC4C(=CC=C(F)C=4F)N=3)N=C(N=C12)N1CCOCC1 InChiKey:
US$ 1271.94
US$ 4578.45
US$ 2057.08
US$ 42.00